Skip to content
lifestyle.goodsciencing.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Relmada Therapeutics
Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing
March 9, 2026
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
March 9, 2026
←
Previous Page
1
2